323 related articles for article (PubMed ID: 28423603)
61. Knockdown of galectin-1 suppresses the growth and invasion of osteosarcoma cells through inhibition of the MAPK/ERK pathway.
Miao JH; Wang SQ; Zhang MH; Yu FB; Zhang L; Yu ZX; Kuang Y
Oncol Rep; 2014 Oct; 32(4):1497-504. PubMed ID: 25069486
[TBL] [Abstract][Full Text] [Related]
62. Silencing of Eag1 Gene Inhibits Osteosarcoma Proliferation and Migration by Targeting STAT3-VEGF Pathway.
Wu X; Chen Z; Zeng W; Zhong Y; Liu Q; Wu J
Biomed Res Int; 2015; 2015():617316. PubMed ID: 26783521
[TBL] [Abstract][Full Text] [Related]
63. Adipose-derived stem cells promote tumor initiation and accelerate tumor growth by interleukin-6 production.
Wei HJ; Zeng R; Lu JH; Lai WF; Chen WH; Liu HY; Chang YT; Deng WP
Oncotarget; 2015 Apr; 6(10):7713-26. PubMed ID: 25797257
[TBL] [Abstract][Full Text] [Related]
64. Epigenetic Profiling Identifies LIF as a Super-enhancer-Controlled Regulator of Stem Cell-like Properties in Osteosarcoma.
Lu B; He Y; He J; Wang L; Liu Z; Yang J; Gao Z; Lu G; Zou C; Zhao W
Mol Cancer Res; 2020 Jan; 18(1):57-67. PubMed ID: 31615908
[TBL] [Abstract][Full Text] [Related]
65. Secretion of interleukin-6 by bone marrow mesenchymal stem cells promotes metastasis in hepatocellular carcinoma.
Mi F; Gong L
Biosci Rep; 2017 Aug; 37(4):. PubMed ID: 28659496
[TBL] [Abstract][Full Text] [Related]
66. Involvement of chemokine receptor 4/stromal cell-derived factor 1 system during osteosarcoma tumor progression.
Perissinotto E; Cavalloni G; Leone F; Fonsato V; Mitola S; Grignani G; Surrenti N; Sangiolo D; Bussolino F; Piacibello W; Aglietta M
Clin Cancer Res; 2005 Jan; 11(2 Pt 1):490-7. PubMed ID: 15701832
[TBL] [Abstract][Full Text] [Related]
67. Modeling human osteosarcoma in mice through 3AB-OS cancer stem cell xenografts.
Di Fiore R; Guercio A; Puleio R; Di Marco P; Drago-Ferrante R; D'Anneo A; De Blasio A; Carlisi D; Di Bella S; Pentimalli F; Forte IM; Giordano A; Tesoriere G; Vento R
J Cell Biochem; 2012 Nov; 113(11):3380-92. PubMed ID: 22688921
[TBL] [Abstract][Full Text] [Related]
68. CUL4A expression in pediatric osteosarcoma tissues and its effect on cell growth in osteosarcoma cells.
Li X; Xu R; Liu H; Fang K
Tumour Biol; 2016 Jun; 37(6):8139-44. PubMed ID: 26715273
[TBL] [Abstract][Full Text] [Related]
69. Increased expression of insulin-like growth factor-1 receptor is correlated with tumor metastasis and prognosis in patients with osteosarcoma.
Wang YH; Han XD; Qiu Y; Xiong J; Yu Y; Wang B; Zhu ZZ; Qian BP; Chen YX; Wang SF; Shi HF; Sun X
J Surg Oncol; 2012 Mar; 105(3):235-43. PubMed ID: 21866554
[TBL] [Abstract][Full Text] [Related]
70. The novel curcumin analog FLLL32 decreases STAT3 DNA binding activity and expression, and induces apoptosis in osteosarcoma cell lines.
Fossey SL; Bear MD; Lin J; Li C; Schwartz EB; Li PK; Fuchs JR; Fenger J; Kisseberth WC; London CA
BMC Cancer; 2011 Mar; 11():112. PubMed ID: 21443800
[TBL] [Abstract][Full Text] [Related]
71. Signal transducer and activator of transcription 3-A key molecular switch for human mesenchymal stem cell proliferation.
Levy O; Dvir T; Tsur-Gang O; Granot Y; Cohen S
Int J Biochem Cell Biol; 2008; 40(11):2606-18. PubMed ID: 18583177
[TBL] [Abstract][Full Text] [Related]
72. PKD1 negatively regulates cell invasion, migration and proliferation ability of human osteosarcoma.
Onishi Y; Kawamoto T; Kishimoto K; Hara H; Fukase N; Toda M; Harada R; Kurosaka M; Akisue T
Int J Oncol; 2012 Jun; 40(6):1839-48. PubMed ID: 22426824
[TBL] [Abstract][Full Text] [Related]
73. Monocyte chemotactic protein-1 promotes the proliferation and invasion of osteosarcoma cells and upregulates the expression of AKT.
Chen Q; Sun W; Liao Y; Zeng H; Shan L; Yin F; Wang Z; Zhou Z; Hua Y; Cai Z
Mol Med Rep; 2015 Jul; 12(1):219-25. PubMed ID: 25695619
[TBL] [Abstract][Full Text] [Related]
74. Role of the HDAC6/STAT3 pathway in regulating PD-L1 expression in osteosarcoma cell lines.
Keremu A; Aimaiti A; Liang Z; Zou X
Cancer Chemother Pharmacol; 2019 Feb; 83(2):255-264. PubMed ID: 30430228
[TBL] [Abstract][Full Text] [Related]
75. Bmi‑1‑targeting suppresses osteosarcoma aggressiveness through the NF‑κB signaling pathway.
Liu J; Luo B; Zhao M
Mol Med Rep; 2017 Dec; 16(6):7949-7958. PubMed ID: 28983587
[TBL] [Abstract][Full Text] [Related]
76. Knocking down Siglec-15 in osteosarcoma cells inhibits proliferation while promoting apoptosis and pyroptosis by targeting the Siglec-15/STAT3/Bcl-2 pathway.
Song K; Ma J; Gao Y; Qu Y; Ren C; Yan P; Zheng B; Yue B
Adv Med Sci; 2022 Sep; 67(2):187-195. PubMed ID: 35398779
[TBL] [Abstract][Full Text] [Related]
77. Tumor-derived Exosomes Induced M2 Macrophage Polarization and Promoted the Metastasis of Osteosarcoma Cells Through Tim-3.
Cheng Z; Wang L; Wu C; Huang L; Ruan Y; Xue W
Arch Med Res; 2021 Feb; 52(2):200-210. PubMed ID: 33162186
[TBL] [Abstract][Full Text] [Related]
78. [Twist regulates proliferation, migration and invasion of osteosarcoma cells in vitro].
He Y; Fang SY; Bi Y; He TC; Wang Y; Hong SQ
Nan Fang Yi Ke Da Xue Xue Bao; 2018 May; 38(5):554-560. PubMed ID: 29891451
[TBL] [Abstract][Full Text] [Related]
79. EFEMP1 promotes the migration and invasion of osteosarcoma via MMP-2 with induction by AEG-1 via NF-κB signaling pathway.
Wang Z; Cao CJ; Huang LL; Ke ZF; Luo CJ; Lin ZW; Wang F; Zhang YQ; Wang LT
Oncotarget; 2015 Jun; 6(16):14191-208. PubMed ID: 25987128
[TBL] [Abstract][Full Text] [Related]
80. Synergistic antitumor effect of the activated PPARgamma and retinoid receptors on human osteosarcoma.
He BC; Chen L; Zuo GW; Zhang W; Bi Y; Huang J; Wang Y; Jiang W; Luo Q; Shi Q; Zhang BQ; Liu B; Lei X; Luo J; Luo X; Wagner ER; Kim SH; He CJ; Hu Y; Shen J; Zhou Q; Rastegar F; Deng ZL; Luu HH; He TC; Haydon RC
Clin Cancer Res; 2010 Apr; 16(8):2235-45. PubMed ID: 20371684
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
